{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:30:14Z","timestamp":1791045014965,"version":"4.1.0"},"reference-count":74,"publisher":"The Company of Biologists","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"abstract":"<jats:p>Cell motility is an essential element of tumor dissemination, allowing organ infiltration by cancer cells. Using mouse LB lymphoma cells transfected with standard CD44 (CD44s) cDNA (LB-TRs cells) or with the alternatively spliced CD44 variant CD44v4-v10 (CD44v) cDNA (LB-TRv cells), we explored their CD44-dependent cell migration. LB-TRv cells, but not LB-TRs or parental LB cells, bound soluble hyaluronic acid (HA) and other glycosaminoglycans (GAGs), and exclusively formed, under physiological shear force, rolling attachments on HA substrate. Furthermore, LB-TRv cells, but not LB-TRs cells or their parental LB cells, displayed accelerated local tumor formation and enhanced accumulation in the peripheral lymph nodes after s.c. inoculation. The aggressive metastatic behavior of i.v.-injected LB-TRV cells, when compared with that of other LB-transfectants, is attributed to more efficient migration to the lymph nodes, rather than to local growth in the lymph node. Injection of anti-CD44 monoclonal antibody or of the enzyme hyaluronidase also prevented tumor growth in lymph nodes of BALB\/c mice inoculated with LB-TRv cells. The enhanced in vitro rolling and enhanced in vivo local tumor growth and lymph node invasion disappeared in LB cells transfected with CD44v cDNA bearing a point mutation at the HA binding site, located at the distal end of the molecule constant region. These findings show that the interaction of cell surface CD44v with HA promotes cell migration both in vitro and in vivo, and they contribute to our understanding of the mechanism of cell trafficking, including tumor spread.<\/jats:p>","DOI":"10.1242\/jcs.114.19.3463","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T23:39:26Z","timestamp":1619393966000},"page":"3463-3477","source":"Crossref","is-referenced-by-count":38,"title":["CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes"],"prefix":"10.1242","volume":"114","author":[{"given":"Shulamit B.","family":"Wallach-Dayan","sequence":"first","affiliation":[{"name":"The Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem, 91120 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Grabovsky","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Weizmann Institute, Rehovot, 76100 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju\u0308rgen","family":"Moll","sequence":"additional","affiliation":[{"name":"Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, Karlsruhe D-76021, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sleeman","sequence":"additional","affiliation":[{"name":"Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, Karlsruhe D-76021, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Herrlich","sequence":"additional","affiliation":[{"name":"Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, Karlsruhe D-76021, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Alon","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Weizmann Institute, Rehovot, 76100 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Naor","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem, 91120 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042522554016800_ALON-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Alon, R., Kassner, P. D., Carr, M. W., Finger, E. B., Hemler, M. E. and Springer, T. A. (1995). The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128, 1243-1253.","DOI":"10.1083\/jcb.128.6.1243"},{"key":"2021042522554016800_ARUFFO-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B. and Seed, B. (1990). CD44 is the principal cell surface receptor for hyaluronate. Cell61, 1303-1313.","DOI":"10.1016\/0092-8674(90)90694-A"},{"key":"2021042522554016800_BARTOLAZZI-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Bartolazzi, A., Peach, R., Aruffo, A. and Stamenkovic, I. (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med.180, 53-66.","DOI":"10.1084\/jem.180.1.53"},{"key":"2021042522554016800_BARTOLAZZI-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Bartolazzi, A., Jackson, D., Bennett, K., Aruffo, A., Dickinson, R., Shields, J., Whittle, N. and Stamenkovic, I. (1995). Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci.108, 1723-1733.","DOI":"10.1242\/jcs.108.4.1723"},{"key":"2021042522554016800_BENNETT-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos. E., Peach. R., Modrell, B., Stamenkovic, I., Plowman, G. and Aruffo, A. (1995). CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol.128, 687-698.","DOI":"10.1083\/jcb.128.4.687"},{"key":"2021042522554016800_BERLIN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Berlin, C., Bargatze, R. F., von Andrian, U. H., Szabo, M. C., Hasslen, S. R., Nelson, R. D., Berg, E. L., Erlandsen, S. L. and Butcher, E. C. (1995). \u03b14 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell80, 413-422.","DOI":"10.1016\/0092-8674(95)90491-3"},{"key":"2021042522554016800_CHISHIMA-ETAL-1997","unstructured":"Chishima, T., Miyagi, Y., Wang, X., Yamaoka, H., Shimada, H., Moossa, A. R. and Hoffman R. M. ( 1997). Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res.57, 2042-2047."},{"key":"2021042522554016800_CLARK-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Clark, R. A., Alon, R. and Springer, T. A. (1996). CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol.134, 1075-1087.","DOI":"10.1083\/jcb.134.4.1075"},{"key":"2021042522554016800_DAVIGNON-ETAL-1981","doi-asserted-by":"crossref","unstructured":"Davignon, D., Martz, E., Reynolds, T., Ku\u0308rzinger, K. and Springer, T. A. (1981). Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA78, 4535-4539.","DOI":"10.1073\/pnas.78.7.4535"},{"key":"2021042522554016800_DE-ALAVA-ETAL-1998","doi-asserted-by":"crossref","unstructured":"de Alava, E., Panizo, A., Sola, I., Rodri\u0301guez-Rubio, F. I. and Pardo-Minda\u0301n, F. J. (1998). CD44v6 expression is related to progression in renal epithelial tumours. Histopathology33, 39-45.","DOI":"10.1046\/j.1365-2559.1998.00429.x"},{"key":"2021042522554016800_DE-BELDER-AND-WIK-1975","doi-asserted-by":"crossref","unstructured":"de Belder, A. N. and Wik, K. O. (1975). Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res.44, 251-257.","DOI":"10.1016\/S0008-6215(00)84168-3"},{"key":"2021042522554016800_DEGRENDELE-ETAL-1996","doi-asserted-by":"crossref","unstructured":"DeGrendele, H. C., Estess, P., Picker, L. J. and Siegelman, M. H. (1996). CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med.183, 1119-1130.","DOI":"10.1084\/jem.183.3.1119"},{"key":"2021042522554016800_DEGRENDELE-ETAL-1997A","doi-asserted-by":"crossref","unstructured":"DeGrendele, H. C., Estess, P. and Siegelman, M. H. (1997a). Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science278, 672-675.","DOI":"10.1126\/science.278.5338.672"},{"key":"2021042522554016800_DEGRENDELE-ETAL-1997B","doi-asserted-by":"crossref","unstructured":"DeGrendele, H. C., Kosfiszer, M., Estess, P. and Siegelman, M. H. (1997b). CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol.159, 2549-2553.","DOI":"10.4049\/jimmunol.159.6.2549"},{"key":"2021042522554016800_DIMILLA-ETAL-1993","doi-asserted-by":"crossref","unstructured":"DiMilla, P. A., Stone, J. A., Quinn, J. A., Albelda, S. M. and Lauffenburger, D. A. (1993). Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J. Cell Biol.122, 729-737.","DOI":"10.1083\/jcb.122.3.729"},{"key":"2021042522554016800_DUBAND-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Duband, J. L., Nuckolls, G. H., Ishihara, A. and Hasegawa T. (1988). Fibronectin receptor exhibits high lateral mobility in embryonic locomoting cells but is immobile in focal contacts and fibrillar streaks in stationary cells. J. Cell Biol.107, 1385-1396.","DOI":"10.1083\/jcb.107.4.1385"},{"key":"2021042522554016800_ENGLISH-ETAL-1998","unstructured":"English, N., Lesley, J. and Hyman, R. (1998). Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res.58, 3736-3742."},{"key":"2021042522554016800_ESTESS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Estess, P., DeGrendele, H. C., Pascual, V. and Siegelman, M. H. (1998). Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J. Clin. Invest.102, 1173-1182.","DOI":"10.1172\/JCI4235"},{"key":"2021042522554016800_FRASER-AND-LAURENT-1989","unstructured":"Fraser, J. R. E. and Laurent, T. C. (1989). Turnover and metabolism of hyaluronan. Ciba Found. Symp.143, 41-59."},{"key":"2021042522554016800_GALLATIN-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Gallatin, W. M., Weissman, I. L. and Butcher, E. C. (1983). A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature304, 30-34.","DOI":"10.1038\/304030a0"},{"key":"2021042522554016800_GUUMLNTHERT-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Gu\u0308nthert, U., Hoffmann, M., Rudy, W., Reber, S., Zo\u0308ller, M., Hau\u00dfmann, I., Matzku, S., Wenzel, A., Ponta, H. and Herrlich, P. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell65, 13-24.","DOI":"10.1016\/0092-8674(91)90403-L"},{"key":"2021042522554016800_GUO-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Guo, Y.-J., Wong, J.-H., Lin, S.-C., Aruffo, A., Stamenkovic, I. and Sy, M.-S. (1994). Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin molecules. Cell Immunol.154, 202-218.","DOI":"10.1006\/cimm.1994.1069"},{"key":"2021042522554016800_HERRLICH-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Herrlich, P., Rudy, W., Hofmann, M., Arch, R., Zo\u0308ller, M., Zawadzki, V., To\u0308lg, C., Hekele, A., Koopman, G., Pals, S. et al. (1993). CD44 and splice variants of CD44 in normal differentiation and tumor progression. In Cell Adhesion Molecules (ed. M. E. Hemler and E. Mihich), pp. 265-288. New York: Plenum Press.","DOI":"10.1007\/978-1-4615-2830-2_17"},{"key":"2021042522554016800_HO-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene77, 51-59.","DOI":"10.1016\/0378-1119(89)90358-2"},{"key":"2021042522554016800_ILANGUMARAN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ilangumaran, S., Borisch, B. and Hoessli, D. C. (1999). Signal transduction via CD44: role of plasma membrane microdomains. Leuk. Lymphoma.35, 455-469.","DOI":"10.1080\/10428199909169610"},{"key":"2021042522554016800_JONES-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Jones, M., Tussey, L., Athanasou, N. and Jackson, D. (2000). Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth action. J. Biol. Chem.275, 7964-7974.","DOI":"10.1074\/jbc.275.11.7964"},{"key":"2021042522554016800_KASTAN-ETAL-1991","unstructured":"Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res.51, 6304-6311."},{"key":"2021042522554016800_KUROZUMI-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Kurozumi, K., Nakao, K., Nishida, T., Nakahara, M., Ogino, N. and Tsujimoto, M. (1998). Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma. World J. Surg.22, 1237-1242.","DOI":"10.1007\/s002689900551"},{"key":"2021042522554016800_LAUFFENBURGER-1991","doi-asserted-by":"crossref","unstructured":"Lauffenburger, D. A. (1991). Models for receptor-mediated cell phenomena: adhesion and migration. Annu. Rev. Biophys. Chem.20, 387-414.","DOI":"10.1146\/annurev.bb.20.060191.002131"},{"key":"2021042522554016800_LAWRENCE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Lawrence, M. B., Bainton, D. F. and Springer, T. A. (1994). Neutrophil tethering to and rolling on E-selectin are separable by requirement for L-selectin. Immunity1, 137-145.","DOI":"10.1016\/1074-7613(94)90107-4"},{"key":"2021042522554016800_LEE-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Lee, T. H., Wisniewski, H.-G. and Vilc\u2032ek, J. (1992). A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol.116, 545-557.","DOI":"10.1083\/jcb.116.2.545"},{"key":"2021042522554016800_LESLEY-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R. and Kincade, P. W. (1992). Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med.175, 257-266.","DOI":"10.1084\/jem.175.1.257"},{"key":"2021042522554016800_LESLEY-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Lesley, J., Hyman, R. and Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv. Immunol.54, 271-335.","DOI":"10.1016\/S0065-2776(08)60537-4"},{"key":"2021042522554016800_LESLEY-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R. (1995). Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med.182, 431-437.","DOI":"10.1084\/jem.182.2.431"},{"key":"2021042522554016800_MALONEY-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Maloney, D. G., Kaminski, M. S., Burowski, D., Haimovich, J. and Levy, R. (1985). Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma4, 191-209.","DOI":"10.1089\/hyb.1985.4.191"},{"key":"2021042522554016800_MEREDITH-AND-SCHWARTZ-1997","doi-asserted-by":"crossref","unstructured":"Meredith, J. E., Jr and Schwartz, M. A. (1997). Integrins, adhesion and apoptosis. Trends Cell Biol.7, 146-150.","DOI":"10.1016\/S0962-8924(97)01002-7"},{"key":"2021042522554016800_MIYAKE-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Miyake, K., Medina, K. L., Hayashi, S.-I., Ono, S., Hamaoka, T. and Kincade, P. W. (1990). Monoclonal antibodies to Pgp-1\/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med.171, 477-488.","DOI":"10.1084\/jem.171.2.477"},{"key":"2021042522554016800_MOHAMADZADEH-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Mohamadzadeh, M., DeGrendele, H., Arizpe, H., Estess, P. and Siegelman M. (1998). Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44\/HA-dependent primary adhesion. J. Clin. Invest. 101, 97-108.","DOI":"10.1172\/JCI1604"},{"key":"2021042522554016800_MOLL-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Moll, J., Schmidt, A., van der Putten, H., Plug, R., Ponta, H., Herrlich, P. and Zo\u0308ller, M. (1996). Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J. Immunol.156, 2085-2094.","DOI":"10.4049\/jimmunol.156.6.2085"},{"key":"2021042522554016800_NAOR-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Naor, D., Vogt Sionov, R. and Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv. Cancer Res.71, 241-319.","DOI":"10.1016\/S0065-230X(08)60101-3"},{"key":"2021042522554016800_OLIFERENKO-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwa\u0308rzler, C., Schwarz, H., Beug, H., Gu\u0308nthert, U. and Huber, L. A. (1999). Analysis of CD44-containing lipid rafts: recruitment of Annexin II and stablization by the actin cytoskeleton. J. Cell Biol.146, 843-854.","DOI":"10.1083\/jcb.146.4.843"},{"key":"2021042522554016800_PEACH-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Peach, R. J., Hollenbaugh, D., Stamenkovic, I. and Aruffo, A. (1993). Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol.122, 257-264.","DOI":"10.1083\/jcb.122.1.257"},{"key":"2021042522554016800_RALL-AND-RUSTGI-1995","unstructured":"Rall, C. J. N. and Rustgi, A. K. (1995). CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res.55, 1831-1835."},{"key":"2021042522554016800_ROCHMAN-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Rochman, M., Moll, J., Herrlich, P., Wallach, S. B., Nedvetzki, S., Vogt Sionov, R., Golan, I., Ish-Shalom, D. and Naor, D. (2000). The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation. Cell Adhes. Commun.7, 331-347.","DOI":"10.3109\/15419060009015004"},{"key":"2021042522554016800_RUGGIERO-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Ruggiero, R. A., Bustuoabad, O. D., Bonfil, R. D., Meiss, R. P. and Pasqualini, C. D. (1985). \u2018Concomitant immunity\u2019 in murine tumours of non-detectable immunogenicity. Br. J. Cancer51, 37-48.","DOI":"10.1038\/bjc.1985.6"},{"key":"2021042522554016800_SALLES-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Salles, G., Zain, M., Jiang, W., Boussiotis, V. A. and Shipp, M. A. (1993). Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood82, 3539-3547.","DOI":"10.1182\/blood.V82.12.3539.3539"},{"key":"2021042522554016800_SANCHEZ-MADRID-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Sanchez-Madrid, F., Simon, P., Thompson, S. and Springer, T. A. (1983). Mapping of antigenic and functional epitopes on the \u03b1- and \u03b2-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1. J. Exp. Med.158, 586-602.","DOI":"10.1084\/jem.158.2.586"},{"key":"2021042522554016800_SCOTT-1961","doi-asserted-by":"crossref","unstructured":"Scott, J. E. (1961). The precipitation of polyanions by long-chain aliphatic ammonium salts. Biochem. J.81, 418-424.","DOI":"10.1042\/bj0810418"},{"key":"2021042522554016800_SCREATON-ETAL-1993","unstructured":"Screaton, G. R., Bell, M. V., Bell, J. I. and Jackson, D. G. (1993). The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J. Biol. Chem.268, 12235-12238."},{"key":"2021042522554016800_SHERMAN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Sherman, L., Wainwright, D., Ponta, H. and Herrlich, P. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev.12, 1058-1071.","DOI":"10.1101\/gad.12.7.1058"},{"key":"2021042522554016800_SKELTON-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Skelton, T. P., Zeng, C., Nocks, A. and Stamenkovic, I. (1998). Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol.140, 431-446.","DOI":"10.1083\/jcb.140.2.431"},{"key":"2021042522554016800_SLEEMAN-ETAL-1996A","doi-asserted-by":"crossref","unstructured":"Sleeman, J., Rudy, W., Hoffmann, M., Moll, J., Herrlich, P. and Ponta, H. (1996a). Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol.135, 1139-1150.","DOI":"10.1083\/jcb.135.4.1139"},{"key":"2021042522554016800_SLEEMAN-ETAL-1996B","unstructured":"Sleeman, J. P., Arming, S., Moll, J. F., Hekele, A., Rudy, W., Sherman, L. S., Kreil, G., Ponta, H. and Herrlich, P. (1996b). Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res.56, 3134-3141."},{"key":"2021042522554016800_SLEEMAN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Sleeman, J. P., Kondo, K., Moll, J., Ponta, H. and Herrlich, P. (1997). Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 272, 31837-31844.","DOI":"10.1074\/jbc.272.50.31837"},{"key":"2021042522554016800_SPRINGER-ETAL-1979","doi-asserted-by":"crossref","unstructured":"Springer, T., Galfre\u0301, G., Secher, D. S. and Milstein, C. (1979). Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol.9, 301-306.","DOI":"10.1002\/eji.1830090410"},{"key":"2021042522554016800_SPRINGER-1994","doi-asserted-by":"crossref","unstructured":"Springer, T. A. ( 1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell76, 301-314.","DOI":"10.1016\/0092-8674(94)90337-9"},{"key":"2021042522554016800_STAUDER-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Stauder, R., Eisterer, W., Thaler, J. and Gu\u0308nthert, U. (1995). CD44 variant isoforms in non-Hodkin\u2019s lymphoma: a new independent prognostic factor. Blood85, 2885-2899.","DOI":"10.1182\/blood.V85.10.2885.bloodjournal85102885"},{"key":"2021042522554016800_SY-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Sy, M.-S., Guo, Y.-J. and Stamenkovic, I. (1991). Distinct effects of two CD44 isoforms on tumor growth in vitro. J. Exp. Med.174, 859-866.","DOI":"10.1084\/jem.174.4.859"},{"key":"2021042522554016800_TAHER-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Taher, E. I. T., Smit, L., Griffioen, A. W., Schilder-Tol, E. J. M., Borst, J. and Pals, S. T. (1996). Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J. Biol. Chem.271, 2863-2867.","DOI":"10.1074\/jbc.271.5.2863"},{"key":"2021042522554016800_TAKEI-1985","doi-asserted-by":"crossref","unstructured":"Takei, F. (1985). Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol.134, 1403-1407.","DOI":"10.4049\/jimmunol.134.3.1403"},{"key":"2021042522554016800_TANAKA-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U. and Shaw, S. (1993). T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1\u03b2. Nature361, 79-82.","DOI":"10.1038\/361079a0"},{"key":"2021042522554016800_TEMPFER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Tempfer, C., Sliutz, G., Haeusler, G., Speiser, P., Reinthaller, A., Breitenecker, G., Vavra, N. and Kainz, Ch. ( 1998). CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br. J. Cancer78, 1091-1094.","DOI":"10.1038\/bjc.1998.633"},{"key":"2021042522554016800_TIAN-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Tian, B., Takasu, T. and Henke, C. (2000). Functional role of Cyclin A on induction of fibroblast apoptosis due to ligation of CD44 matrix receptor by anti-CD44 antibody. Exp. Cell Res.257, 135-144.","DOI":"10.1006\/excr.2000.4871"},{"key":"2021042522554016800_TOUMLLG-ETAL-1993","doi-asserted-by":"crossref","unstructured":"To\u0308lg, C., Hoffmann, M., Herrlich, P. and Ponta, H. (1993). Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21, 1225-1229.","DOI":"10.1093\/nar\/21.5.1225"},{"key":"2021042522554016800_TROWBRIDGE-ETAL-1982","doi-asserted-by":"crossref","unstructured":"Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J. (1982). Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics15, 299-312.","DOI":"10.1007\/BF00364338"},{"key":"2021042522554016800_VAN-DER-VOORT-ETAL-1999","doi-asserted-by":"crossref","unstructured":"van der Voort, R., Taher, T. E. I., Wielenga, V. J. M., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E. and Pals, S. T. (1999). Heparan sulfate-modified CD44 promotes hepatocyte growth factor\/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem.274, 6499-6506.","DOI":"10.1074\/jbc.274.10.6499"},{"key":"2021042522554016800_VOGT-SIONOV-AND-NAOR-1997","unstructured":"Vogt Sionov, R. and Naor, D. (1997). Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs. Int. J. Cancer71, 462-469."},{"key":"2021042522554016800_WALLACH-ETAL-2000","unstructured":"Wallach, S. B., Friedmann, A. and Naor, D. (2000). The CD44 receptor of the mouse LB T-cell lymphoma: Analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and anti-sense oligonucleotides. Cancer Detect. Prev.24, 33-45."},{"key":"2021042522554016800_WEISS-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Ko\u0308hler, G., Scho\u0308pf, E., Ponta, H., Herrlich, P. and Simon, J. C. (1997). An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dentritic cell function. J. Cell Biol.137, 1137-1147.","DOI":"10.1083\/jcb.137.5.1137"},{"key":"2021042522554016800_WEISS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Weiss, L., Slavin, S., Reich, S., Cohen, P., Shuster, S., Stern, R., Kaganovsky, E., Okon, E., Rubinstein, A. M. and Naor, D. (2000). Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA97, 285-290.","DOI":"10.1073\/pnas.97.1.285"},{"key":"2021042522554016800_YANG-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Yang, B., Yang, B. L. and Goetinck, P. F. (1995). Biotinylated hyaluronic acid as a probe for identifying hyaluronic acid-binding proteins. Anal. Biochem. 228,299-306.","DOI":"10.1006\/abio.1995.1354"},{"key":"2021042522554016800_ZAHALKA-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Zahalka, M. A., Okon, E. and Naor, D. (1993). Blocking lymphoma invasiveness with a monoclonal antibody directed against the \u03b2-chain of the leukocyte adhesion molecule (CD18). J. Immunol.150, 4466-4477.","DOI":"10.4049\/jimmunol.150.10.4466"},{"key":"2021042522554016800_ZAHALKA-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Zahalka, M. A., Okon, E., Gosslar, U., Holzmann, B. and Naor, D. (1995). Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol.154, 5345-5355.","DOI":"10.4049\/jimmunol.154.10.5345"},{"key":"2021042522554016800_ZHOU-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Zhou, D. F. H., Ding, J. F., Picker, L. J., Bargatze, R. F., Butcher, E. C. and Goeddel, D. V. ( 1989). Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J. Immunol.143, 3390-3395.","DOI":"10.4049\/jimmunol.143.10.3390"}],"container-title":["Journal of Cell Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/114\/19\/3463\/1357104\/3463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/114\/19\/3463\/1357104\/3463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T10:45:41Z","timestamp":1724928341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/jcs\/article\/114\/19\/3463\/34895\/CD44-dependent-lymphoma-cell-dissemination-a-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":74,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1242\/jcs.114.19.3463","relation":{},"ISSN":["1477-9137","0021-9533"],"issn-type":[{"value":"1477-9137","type":"electronic"},{"value":"0021-9533","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10,1]]}}}